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ABSTRACT (Total 294 words) 
Background: Transcatheter, bilateral branch pulmonary artery (PA) valve implantation 
is a novel treatment for patients with severe pulmonary insufficiency and oversized right 
ventricle (RV) outflow tract. There is scarce data on efficacy and safety of this approach.  
Methods: This was a retrospective study of 8 patients with repaired Tetralogy of Fallot 
who underwent bilateral branch PA valve implantation. Demographics, 
echocardiography, cardiac catheterization, and axial imaging data were reviewed. 
Variables were compared by a paired sample t-test.  
Results: All patients were adult sized (weight 43 – 99 kg) with oversized RV outflow 
tract not suitable for conventional transcatheter pulmonary valve implantation. Staged 
bare metal PA stenting followed by valve implantation (interval 3-5 months) was 
technically successful in 7 patients with one stent embolization. In another patient 
proximal stent migration prevented placement of bilateral pulmonary valve stents. There 
were a total of 14 valved branch PA stents placed (Melody valve n=9, Sapien XT n=2, 
Sapien 3 n=3). In the 7 patients undergoing successful branch pulmonary valve 
placement, at median follow up of 10 months (range 3 months to 6 years), 13 (93%) 
valves had none/trivial insufficiency on echocardiography. Pre- and post-valve 
implantation cardiac magnetic resonance imaging in five patients showed significant 
reduction of indexed RV end-diastolic volume (152±27 to 105±15 mL/m2, p<0.001). 
Conclusions: Transcatheter, bilateral branch PA valve implantation was technically 
feasible with satisfactory efficacy and safety in patients with repaired Tetralogy of Fallot, 
severe pulmonary insufficiency, and oversized RV outflow tracts. Elimination of 
pulmonary insufficiency with this method resulted in reduced RV end-diastolic volume. 
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This approach can be offered as an alternative to surgery, particularly in patients 
considered high risk for standard surgical placement and who are not candidates for the 
newer self-expanding valve prosthesis for placement in RV outflow tracts larger than 30 
mm diameter. 
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Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect, 
occurring in approximately 1 in 2,518 births in the United States (1). Surgical repair of 
TOF most commonly includes performing a trans-annular patch, resulting in free 
pulmonary insufficiency, which is well tolerated in the pediatric population but often 
results in long-term complications including right ventricular (RV) dilation and 
dysfunction (2, 3), ventricular arrhythmias (4), exercise limitations (5, 6) and sudden 
cardiac death (7). Severe pulmonary insufficiency, together with arrhythmias, symptoms, 
and/or moderate to severe RV enlargement, are indicators for pulmonary valve 
replacement (PVR) (8).  Transcathter pulmomary valve implantation has revolutionized 
the treatment of pulmonary insufficiency, primarily for surgically placed RV to 
pulmonary artery (PA) conduits (9, 10). There is growing experience with valve 
implantation in non-conduit or native right ventricle outflow tracts (RVOT), usually 
preceded by bare metal pre-stenting (11). However, RVOTs greater than 30 mm diameter 
are not suitable for valve implantation due to the limitations of currently available trans-
catheter pulmonary valve sizes (largest diameter Sapien XT valve 29 mm, Edwards 
Lifesciences, Irvine, CA) (12). Therefore, there is a need for alternative trans-catheter 
treatment options in these patients.  
 
Trans-catheter, bilateral branch PA valve implantation has been tested in an ovine model 
(13) and reported in two patients (14, 15). The efficacy and safety of this innovative 
approach in long-term follow-up has not been well described. At our institution, bare 
metal pre-stenting followed by bilateral branch PA valve implantation has been offered as 
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an alternative to surgical valve placement in selected patients with repaired TOF and 
dysfunctional, large RVOT since 2011. This is the first report of this technique with 




This was a retrospective analysis of 8 patients who underwent trans-catheter, bilateral 
branch PA valve implantation at the Children's Hospital of Michigan. In 4 patients, the 
procedure was performed due to other comorbid conditions, which were felt to increase 
the risk of surgical pulmonary valve replacement, though in 4 patients it was offered as a 
primary treatment alternative to surgical pulmonary valve placement (Supplemental 
Table 1).  
 
Data collected on the patients were demographic details of the patients, including patient 
age, sex, race, clinical characteristics, underlying anatomy, medications, details of the 
surgical repair, the results of the CMR as well as the echocardiograms performed at our 
center. The patients were NYHA classified according to their clinical status at time of 
procedure and follow-up. The echocardiograms were acquired at our center using a 
standard institutional protocol. CMR was performed using 1.5 Tesla scanners (GE 
Medical Systems). 1.5 Cine images were obtained using breath-hold SSPE method and 
were analyzed offline to assess the RV and LV end-diastolic volumes and end-systolic 
volumes by manually tracing the cavities at multiple levels by cardiologists and 
radiologists with expertise training. The entire RV was included in the measurement, 
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including the RVOT and the area under the patch. Medis Mass software (version 6) was 
used for the tracings. The cine phase velocity pulse sequence was used to measure the PR 
fraction. The indication for re-establishment of pulmonary valve competence was 
significant RV enlargement (RV end-diastolic volume index ≥150 mL/m2 and/or end 
systolic volume ≥80 mL/m2) and/or symptoms of exercise intolerance due to pulmonary 
insufficiency. Appropriate candidates for bilateral branch PA valve implantation had 
RVOT diameter >27 mm and branch PA diameter <27 mm. Procedural catheterization 
data was also analyzed. Post-valve implantation, patients were followed clinically and 
with repeat echocardiographic, and axial imaging evaluation. All angiographic images 
were reviewed and measured by 2 authors (NB and DK) who were blinded to the clinical 
outcomes, including narrowest PA branch diameter, sizing balloon waist and bare metal 
stent diameters, and valve stent final diameter. All the pre and post MRIs were reviewed 
and re-measured by two individual readers (MJZ and AJ), blinded to the results, with 
expertise in reading cardiac MRIs. All measurements were made at best visualization 
(either antero-posterior or lateral view). The RVOT was measured at its narrowest 
diameter level and the PA was measured in systole at its narrowest diameter. The Wayne 
State University Institutional Research Board approved this study. 
 
Bilateral Branch PA Valve Implantation 
Cardiac catheterization was performed under general anesthesia. The baseline 
hemodynamic study was followed by angiography in the RVOT, PA, and coronary 
arteries. Patients were not thought to be candidates for primary native RVOT pre-stenting 
with valve implantation, due to significantly dilated RVOT >30 mm in 6 patients and 
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instability of a 30 mm diameter balloon inflated in the RVOT in 2 patients (RVOT 
diameter 28.6 mm).  Balloon sizing of the branch PAs were performed using either Z-
Med II or Tyshak II balloon catheters (NuMed, Inc., Hopkinton, NY). Balloon catheters 
that measured 3-4 mm in diameter greater than the largest diameter of the PA during 
systole were used. Balloon stability was achieved and balloon waist was measured.  
 
Branch PA bare metal stent placement was performed prior to valve implantation in 
14/15 PA. Palmaz-XL stents (Cordis Endovascular, Warren, NJ) were delivered with 
NuCLEUS balloon catheters (NuMed Corp, Hopkington, NY), with the intention to 
achieve a "dog-bone" shape in the bare metal stent (Fig. 1). Branch PA valve 
implantation was then performed. In circumstances where there was no discernable waist 
in the bare metal stent, a staged approach was taken to allow for bare metal 
endothelialization to avoid inadvertent stent embolization/malposition during stent valve 
implantation. Patients who underwent a staged approach had branch PA valve 
implantation at a separate catheterization 3-5 months later. Melody valves (Medtronic, 
Minneapolis, MN) were used when narrowest stented diameter was < 24 mm, whereas 
Sapien (XT or 3) valves were used for stented PA's > 24 mm. Post-valve implantation, 
distal PA angiography was performed to show valve function (Fig. 2). If angiography 
raised a concern for valve dysfunction, intracardiac echocardiography was performed. All 
patients were observed overnight and started on aspirin prior to discharge. 
 
Statistical Analysis 
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The data were expressed as median (range), mean ± standard deviation, or frequency (%) 
based on the type and distribution of data. The data before and after valve implantation 
were compared using a paired sample t-test. A p <0.05 was considered as statistically 
significant. The intra-class correlation coefficient (ICC) for inter-rater reliability for our 
two independent MRI readers was calculated. Statistical analysis was performed using 
SPSS version 24 (IBM, Armonk, NY). Cost analysis was performed with the matched 
controls of surgical PVR cases and the direct costs (including equipment, personnel, 
admission charges, medication charges etc) as well as indirect costs were reported. The 
average cost reported per case includes only the successful cases. The costs incurred due 




A total of 8 patients underwent attempted bilateral branch PA valve implantation and 7 
had successful implantation of the valves. (Table 1). 16 PAs were intended for treatment 
in 8 patients with 14 valves successfully implanted in 7 patients. All patients had the 
diagnosis of TOF, 6 patients with trans-annular patch augmentation of the RVOT and 2 
with a limited trans-annular patch with homograft placement. All patients were adult size 
with median weight of 76 kg (range 43 – 99 kg). Baseline transthoracic echocardiography 
showed free pulmonary insufficiency and a dilated right ventricle without RVOT 
obstruction. Pre-procedural axial imaging was cardiac MRI in 7 patients and cardiac 
computed tomography angiography due to the presence of a pacemaker in 1 patient. In all 
patients, the RVOT measured at least 27 mm at it's narrowest on cardiac imaging.   
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Cardiac Catheterization (Table 2) 
Angiography showed a significantly dilated RVOT with a median diameter of 30.6 mm 
(range 28.6 – 34.9 mm), not suitable for trans-catheter pulmonary valve implantation in 
the RVOT. The branch PA had a wide variety of sizes and pulsatility, during balloon 
compliance testing. A smaller / stenotic branch PA (diameter <16 mm by angiography) 
was noted in 6 branch PAs (40%), each with a systolic pressure gradient ≥15 mmHg. 
Larger, dynamic branch PA (diameter >20 mm) was noted in 9 (60%). The waist present 
in the sizing balloon was larger than the narrowest angiographic measurement by 2.9±1.6 
mm.  
 
Pre-stenting was performed in all branch PAs except in one patient (one PA), where the 
left pulmonary artery (LPA) was heavily calcified and non-pulsatile and was thought to 
provide a satisfactory landing zone for the Melody valve. For pre-stenting, primarily 
Palmaz-XL stents were delivered on NuCLEUS balloons. A Genesis-XD stent was used 
in one patient. To ensure that the stents were adequately latched onto contractile branch 
PA, the stent-delivery balloon diameter was chosen significantly larger than the waist of 
sizing balloon by 4.0±1.7 mm. For the branch PA valve implantation, Melody valve was 
used in 9 branch PAs and Sapien valve was used in 5 (Sapien XT n=2, Sapein 3 n=3) 
branch PAs. A Sapien valve was chosen when the narrowest stent diameter was greater 
than 25 mm.  
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Hemodynamic data (Table 3A) showed the immediate positive effect of bilateral branch 
PA valve implantation. RV and distal PA systolic pressures were unchanged. Distal PA 
diastolic and mean pressures significantly increased, due to elimination of pulmonary 
insufficiency. When branch PA stenosis was present, the systolic pressure gradient from 
RV to distal PA was significantly decreased due to relief of PA stenosis by stent 
placement. The final stent diameter was larger than the baseline angiographic branch PA 
diameter by 5.3±2.9 mm. Post-valve placement, distal PA angiography showed effective 
valve function in all except 1 valve, where there was moderate valve insufficiency of a 
Sapien XT valve placed in the LPA.  
 
Bilateral branch PA stenting and valve implantation was technically successful in 7 out of 
8 patients. There was a serious adverse event of stent embolization in one patient while 
retrieving the wire and catheter into the MPA. The embolized stent was successfully 
repositioned in the contralateral branch PA. A second stent was placed in the ipsilateral 
PA by oversizing it further. In another patient, the initial bare metal stent was placed in 
the LPA, though proximal migration was noted, requiring a second stent to be placed 
overlapping the distal 1/2 of the initial stent, latching it on to the LPA.  Due to jailing off 
of the RPA from the proximal bare metal stent, attempts to access the RPA were 
unsuccessful in this patient. This patient did not have bilateral PA valves placed and went 
for surgical placement of the pulmonary valve. There were no other complications. All 
patients were successfully discharged the following day.   
 
Follow-up (Table 3B) 
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Of the seven patients who underwent successful bilateral PA valve stent placement, the 
median clinical follow up was 10 months (range 3 months to 6 years). Symptomatically, 
four patients improved from NYHA class III to II and 3 remained with class II symptoms. 
There have been no instances of endocarditis and no surgical or trans-catheter re-
interventions required. Follow up transthoracic echocardiography showed none or trivial 
valve insufficiency in all but 1 patient having moderate insufficiency of a Sapien XT 
valve in the LPA. Follow-up CMR was performed in 5 patients at median follow up of 2 
years (range 3 months to 6 years). Two patients refused follow-up CMR imaging. RV 
systolic and diastolic volumes were significantly decreased in all 5 patients and RV 
ejection fraction improved in 3 patients (Fig. 3). One patient with severe RV dilation (RV 
end diastolic volume index 195 mL/m2) had a lower ejection fraction despite reduction in 
RV volume. No valve stent fractures were present on follow up chest radiography or 
fluoroscopy in all patients. The intra-class correlation coefficient (ICC) for inter-rater 
reliability for our two independent MRI readers was 0.9 for the RV volumes and 0.8 for 
the RVEF.   
 
Cost Analysis 
We performed cost analysis of this procedure, using 4 adult patients who underwent 
standard uncomplicated surgical valve placement in the RVOT position. Supplemental 
table 2 lists the demographic characteristics of the surgical cohort group, all of which 
were considered low risk. We combined the costs of both the BMS placement procedure 
and bilateral valve stent placement in our bilateral PA valve stent group. The average 
direct costs in the bilateral valve PA stent group ($61,063/patient) were significantly 
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higher than their surgical counterparts ($34,729/patient). As expected, the indirect costs 
were significantly higher in the surgical group ($16,342/patient) versus their trans 
catheter counterparts ($8,799/patient). The overall costs for surgical valve placement was 
$51,071/patient and for the bilateral valved PA stent $69,862/patient, with a differential 
cost just under $19,000 favoring surgical pulmonary valve placement. 
 
DISCUSSION 
This report describes the technical feasibility, safety and efficacy of a staged, trans-
catheter bilateral branch PA valve implantation for treatment of pulmonary insufficiency 
in patients, whose RVOT measurements were too large to accommodate the current 
valve-stent maximal dimensions. This is the largest case series of this approach with 
intermediate follow up data. Implanted valves were fully functional in 13/14 (93%) 
branch PAs. Furthermore, follow-up cardiac MRI showed reduction of the RV volume in 
five patients following valve placement. 
 
Bilateral branch PA valve implantation was first described in an ovine model (13) and 
then in a human by Gillespie et al. in 2011 (14). Technical feasibility was shown, but no 
follow up data was described. The second case was published by Maschietto et al. in 
2013; an 18-year-old male with dilated RVOT and right PA stenosis (15). Short-term (3 
month) follow up data was available, with improved clinical symptoms (NYHA class III 
to II) and RV volume reduction on cardiac MRI.  
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We report a series of 7 patients undergoing successful bilateral valve stent placement in 
the PAs, with a maximum follow up of 6 years, including 5 of the seven patients who 
underwent follow-up cardiac MRI. All implanted valves have remained functional 
without need for re-intervention, except one case of moderate valve insufficiency of the 
Sapien XT valve in the LPA, which is being followed conservatively. This valve was 
implanted on a smaller, pre-stented LPA (narrowest diameter 19 mm) using 26 mm 
Sapien valve. The final diameter of valve measured 22.6 mm, with moderate 
insufficiency noted by ICE imaging. We speculate that the valve insufficiency was 
secondary to not achieving full expansion of the Sapien valve, thereby not allowing full 
coaptation of the valve leaflets. Due to this experience, our practice has changed towards 
implanting a Melody valve when possible, which is more likely to be functional, even if 
not fully expanded.  
 
This is a relatively new and experimental approach, which may be as effective in 
improving RV volume and hemodynamics as conventional RVOT valve implantation in 
patients with severe pulmonary insufficiency. Although our cohort had only 5 patients 
with follow up cardiac MRI, our data suggests that bilateral branch PA valve 
implantation had a favorable effect on RV volume and function. It is not uncommon in 
the repaired TOF population to have mild LV dysfunction, as a consequence of inter-
ventricular interactions from a dilated RV. However, the LV ejection fraction did not 
change in our cohort post valve implantation.  In our cohort, one patient (patient #5) had 
lower RV ejection fraction post-valve implantation. We speculate that this RV failed to 
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remodel due to pre-procedural excessive RV volume overload (RV end diastolic volume 
index 195 mL/m2).  
 
In patients with larger PAs (> 22 mm), no PA stenosis, and absence of a balloon waist 
during sizing, we advocate a staged approach of bare metal PA stenting followed by 
valve implantation to create the solid landing zone for the valve stent. Our patients were 
brought back for valve implantation 3-5 months following initial bare metal PA stenting. 
Though there is no direct evidence when stents endothelialize, we believe this interval 
allows for endothelialization of the stent to the vascular wall, as suggested by animal 
studies on coronary stents which endothelialize in 2-3 weeks (16), preventing inadvertent 
stent embolization during subsequent valve stent implantation.  Pre-stenting was 
performed in all branch PAs except in our first patient (one PA). In contrast to a 
homograft, the PA’s have significantly less mobility, torque, and compressive forces 
resulting in fewer fractures. This is supported by the fact that RV to PA conduit stent 
fractures are significantly more common than PA stent fractures (17, 18). 
 
In our opinion, balloon sizing is essential, as angiography underestimates the size and 
compliance of the pulsatile branch PAs. Our choice of stent delivery balloon for large 
branch PAs is the NuCLEUS balloon catheter (Numed Corp, Hopkington, NY), with a 
unique design incorporating a waist in the mid portion of the balloon. At a specified 
pressure, the central waist is designed to expand to 90% of the rated balloon diameter. 
When positioning the stent for delivery, the middle of NuCLEUS balloon catheter is 
positioned at the narrowest portion of branch PA (Fig. 1). Using this technique, the stent 
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can be shaped as a dog-bone, flaring both the proximal and distal ends. This can 
minimize the risk of stent embolization and provide a better landing zone for the 
subsequently placed valve stent. A recently available alternative is the larger Balloon in 
Balloon (BIB) catheters, which also allow for precise positioning of larger stents.   
 
There was one unsuccessful patient in whom the decision to implant bilateral stented 
valves was aborted. This was a 37-year-old female with TOF status post trans annular 
patch repair who has NYHA class III heart failure symptoms. Her cardiac MRI showed 
dilated RV with iRVEDV of 130 ml/m2. She was brought to the lab with the possibility 
of stents to be placed in her branch PA as her RVOT measured 34 mm at its narrowest 
segment. Since the Tyshak II 25X4 latched well in the proximal LPA segment a stent was 
mounted on the Nucleus 25x5 balloon catheter and advanced to the proximal LPA. Even 
though the initial appearance of the stent was satisfactory and there was no contrast 
observed around the stent on post-stent angiography, proximal displacement of the stent 
occurred during balloon withdrawal. Another Palmaz XL4010 stent was mounted on a 
Zmed II 26 x 4 cm Balloon catheter and advanced to the proximal LPA to overlap the 
distal part of the previously placed stent. Unfortunately, due to jailing off of the proximal 
RPA, further attempts to access the RPA were unsuccessful and the procedure aborted. 
She was referred to surgical PVR.  
 
In a cost analysis study from the U.S. markets, between trans-catheter pulmonary valve 
implantation and surgical PVR, although the cost for the Melody device and Ensemble 
(Medtronic, Minneapolis, Minnesota) delivery catheters were higher than the cost of the 
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homograft/surgical valve, the hospital costs and physician fees were lower, which 
resulted in almost equivalent total costs (19). Vergales et al. noted a 5-year societal cost 
attributed to percutaneous PVR of $106,276 and that for the traditional surgical conduit 
replacement at 5 years being higher at $141,273 (20).  
 
In our experience, this advantage favoring standard Melody valve placement in the 
RVOT position is eliminated in patients undergoing bilateral pulmonary valve stent 
placement. Surgical placement of pulmonary valves had lower overall costs than bilateral 
pulmonary valve stent placement. Though the surgical cohort were considered all low 
risk patients, with the bilateral pulmonary valve cohort having 4 moderate to high 
surgical risk, certainly the costs favor surgical valve placement in the low risk group. We 
also recognize that the endocarditis risk may be doubled, given the presence of two valve 
substrates. At this time, the physiologic implications of the RVOT dead space following 
bilateral branch PA valve implantation are unclear. It also remains unknown how the RV 
volume and function would be affected long-term with this procedure, though the early 
results are encouraging.   
 
Soon, larger stents will be available for use in patients with transannular patch 
augmentation of the RVOT with dimensions > 30 mm in diameter.  The Medtronic 
Harmony transcatheter pulmonary valve (Medtronic, Minneapolis, MN) is designed to 
treat larger native RVOT, with encouraging results shown in an early feasibility study 
(21), with a pivotal investigational device exemption study currently underway (22).  
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Even with the development of oversized self-expanding stents, bilateral valve stent 
placement in the PA's may still play a role in a select group of patients.  A recent paper 
by Lindsay et al, noted 9% of their patients showing aortic root compression in patients 
with stents being placed in the RVOT, especially oversized stents, such as the Sapien 
valve stent (23). Thus, we feel this technique described in our paper may still have 
relevance even after introduction of the larger stent size valve series. 
 
Limitations 
This was a retrospective study with an inherent limitation. Our cohort was small, 
although this is the largest series describing this technique. Follow-up CMR was not 
obtained in 2 patients, due to loss to follow-up. We do not believe this affects the 
reporting of our post-valve CMR data. However, the possibility of a selection bias cannot 
be excluded.  
 
CONCLUSION 
Trans-catheter, bilateral branch PA valve implantation was technically feasible with 
satisfactory hemodynamic benefit and safety for the treatment of severe pulmonary 
insufficiency in patients with repaired TOF and oversized RVOT.  Competency of the 
valves placed in the branch PAs resulted in RV volume reduction by CMR. However, the 
in-hospital costs were significantly higher in the bilateral pulmonary valve group. This 
technique could be offered to patients as an alternative to surgery, though we would 
recommend this procedure, after consultation with the surgeons, only to patients 
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considered moderate to high risk for standard surgical placement of a pulmonary valve in 
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Figure 1. Pre-stenting and Melody valve placement, proximal right pulmonary artery 
(RPA). (A) Baseline angiography shows a pulsatile proximal RPA. In systole, there is 
mild narrowing (b: 20.2 mm) compared to distal (a: 27.2 mm) and proximal (c: 27.3 mm) 
segment of RPA. (B) Balloon sizing of RPA shows a minimal balloon waist of 23.2 mm. 
(C) Pre-stenting using a Palmaz-XL 4010 stent mounted on a 25 mm x 4 cm NuCLEUS 
balloon catheter through a 12-Fr Flexor sheath. The stent is implanted so that a dog-bone 
shape is achieved to avoid embolization. (D) Post-stent angiography shows mild stent 
waist (b: 21.7 mm), compared to the distal (a: 24.9 mm) and proximal (24.9 mm) ends of 
stent. (E) Melody valve placement in RPA. Melody TPV 22 (PB1018) is implanted on 24 
mm x 4 cm NuMed BIB catheter. (F) Post-Melody in RPA. There is no insufficiency of 
Melody valve.  
Figure 2. Pre- and post-bilateral branch pulmonary artery (PA) valve implantation. (A) 
Baseline PA angiography. Right ventricular outflow tract is dilated. Proximal LPA is 
heavily calcified with no stenosis or pulsatility. There is a stent in proximal RPA. (B) 
Post-valve implantation. Simultaneous bilateral distal PA angiography shows no valve 
insufficiency. In this case, pre-stenting was not performed in the LPA due to a 
satisfactory landing zone.  
Figure 3. Comparison of cardiac magnetic resonance imaging before and after bilateral 
branch pulmonary artery valve implantation in five patients.  
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Figure 1. Pre-stenting and Melody valve placement, proximal right pulmonary artery (RPA). (A) Baseline 
angiography shows a pulsatile proximal RPA. In systole, there is mild narrowing (b: 20.2 mm) compared to 
distal (a: 27.2 mm) and proximal (c: 27.3 mm) segment of RPA. (B) Balloon sizing of RPA shows a minimal 
balloon waist of 23.2 mm. (C) Pre-stenting using a Palmaz-XL 4010 stent mounted on a 25 mm x 4 cm 
NuCLEUS balloon catheter through a 12-Fr Flexor sheath. The stent is implanted so that a dog-bone shape is 
achieved to avoid embolization. (D) Post-stent angiography shows mild stent waist (b: 21.7 mm), compared 
to the distal (a: 24.9 mm) and proximal (24.9 mm) ends of stent. (E) Melody valve placement in RPA. 
Melody TPV 22 (PB1018) is implanted on 24 mm x 4 cm NuMed BIB catheter. (F) Post-Melody in RPA. There 
is no insufficiency of Melody valve.  
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Figure 2. Pre- and post-bilateral branch pulmonary artery (PA) valve implantation. (A) Baseline PA 
angiography. Right ventricular outflow tract is dilated. Proximal LPA is heavily calcified with no stenosis or 
pulsatility. There is a stent in proximal RPA. (B) Post-valve implantation. Simultaneous bilateral distal PA 
angiography shows no valve insufficiency. In this case, pre-stenting was not performed in the LPA due to a 
satisfactory landing zone.  
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Figure 3. Comparison of cardiac magnetic resonance imaging before and after bilateral branch pulmonary 
artery valve implantation in five patients.  
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1 57 M 76.6 III 139 77 45% 35% 27.3 10 15.6 
2 36 M 82 III 122 74 40% 35% 27.9 18.9 8.6 
3 26 F 43.7 II 146 87 40% 69% 31.2 22.2 14.2 
4 20 F 61.1 II 162 85 47% 46% 31.8 21.3 19.8 
5 49 F 89.3 III 195 115 41% 61% 29.5 19.8 16.4 
6 16 M 55.9 II 149 94 37% 39% 31.5 22.8 10.7 
7 67 M 99.8 III NA* 30.9 20.8 25.4 
Abbreviations: RVEDV, right ventricle end diastolic volume; RVESV, right ventricle end systolic 
volume; RVOT, right ventricle outflow tract; RPA, right pulmonary artery; LPA, left pulmonary artery 
*Cardiac CT angiography was used as a pre-procedural assessment, because of presence of pacemaker.  
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RPA 10.9 NA 
Genesis PG 
3910 
Z-Med II 16mm 
x 2 cm 
15 5 Melody 18 None 14.3 
LPA 15.2 16.4 
No pre-stenting done due to heavily 
calcified LPA 
 Melody 18 None 18.5 
2 




mm x 4 cm 
21.3 
4 
Melody 22 None 22.9 
LPA 12.3 13.5 
Palmaz XL 
P4010 
Z-Med II 20 
mm x 2 cm 
18.0 Melody 20 None 20.2 
3 




mm x 4 cm 
22.3 
5 
Melody 24 None 22.6 
LPA 9.3 15.9 
Palmaz XL 
P3110 
BIB 22 mm x 4 
cm 
22.3 Melody 24 None 21.7 
4 




mm x 4 cm 
21.7 
4 
Melody 24 None 23.4 




mm x 4 cm 
19.2 Melody 24 None 23.6 
5 









29 None 26.0 








26 Moderate 22.6 
6 









29 None 26.5 
LPA* 10.9 15.3 
Palmaz XL 
P3110 
BIB 18 mm x 4 
cm 
15.2 Melody 20 None 17.4 
7 









29 None 28 








29 None 28 
*LPA stent embolization: Initially, LPA was stented by 29 mm length Genesis XD mounted on 16 mm 
x 3 cm Z-Med II balloon. This stent embolized into the main pulmonary artery and re-positioned in the 
proximal stented RPA, followed by further dilation using a 24 mm x 4 cm ATLAS Gold balloon.  
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Table 3. Improvement of clinical variables before and after bilateral branch pulmonary artery valve 
implantation 
 





Systolic (mmHg) 40±14 35±5 
% systemic 42±12 38±8 
Distal PA 
pressure 
Systolic (mmHg) 28±12 29±4 
Diastolic (mmHg) 7±4 12±3 
Mean (mmHg) 15±5 19±3 
Systolic pressure gradient (mmHg) 13±9 6±7 
Angiography 
Narrowest diameter of branch PA (mm) 16.3±4.7 21.7±3.5 
Valve insufficiency 
None/trivial 0 13/14 (93%) 
Mild 0 0 
Moderate 0 1/14 (7%) 
Severe 7/7 (100%) 0 
 
(B) Follow up data 





Class II 3/7 (43%) 7/7 (100%) 
NA 
Class III 4/7 (57%) 0 
Cardiac MRI 
(4 patients) 
RV end diastolic volume index (mL/m2) 150±27 105±15 <0.001 
RV end systolic volume index (mL/m2) 90±18 63±17 <0.001 
RV ejection fraction (%) 40±3 40±13 0.43 
 LV ejection fraction (%) 60±3 59±5 NA 
Echocardiography Valve insufficiency 
None/trivial 0 13/14 (93%) 
NA 
Mild 0 0 
Moderate 0 1/14 (7%) 
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Supplemental Table 1: Reasons for bilateral branch PA valve implantation 
 
Patient # Reason for bilateral branch PA valve implantation 
1 Ventricular tachycardia induced relatively poor cardiac function s/p ICD 
implantation 
2 Tachyarrhythmia induced relatively poor cardiac function 
3 Patient preference 
4 Tachyarrhythmia induced relatively poor cardiac function 
5 Patient preference 
6 Patient preference 
7 Relatively Poor Cardiac function 






Supplemental Table 2: Surgical PVR comparative group 
 
Pt Age (year) Gender Weight (kg) Length of Stay 
1 16 M 115 4 
2 32 M 71 4 
3 16 F 76 4 
4 19 M 91 6 
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